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Abstract 
 
Type 2 diabetes (T2D) is a public health problem of great concern. Globally it is 
increasing and it generates a huge economic burden to society and problems for the 
individuals. Whole grain has shown to have a protective role against T2D in epide-
miological studies and underlying mechanisms are poorly understood, but de-
creased energy intake, higher insulin sensitivity and improved glucose tolerance 
have been suggested and partly confirmed in studies. Alkylresorcinols (AR) are 
phenolic lipids found in different homologs only in the outer parts of wheat and rye 
among commonly consumed foods. It is used as a biomarker of whole grain for rye 
and wheat intake. The Finnish Diabetes Prevention Study (DPS) started in 1993 
with the purpose to evaluate if an intensive diet- and exercise program could pre-
vent or delay T2D in persons with impaired glucose tolerance (IGT). The aim of 
this study was to investigate if there was a difference in whole grain cereal intake 
among non-diabetics and people who developed diabetes under a period of 8 years. 
A fraction of the subjects in the (DPS) was studied. The aim was also to investigate 
differences in whole grain intake between participants who got lifestyle intervention 
and those who did not. Plasma AR was measured and used as a proxy of whole 
grain rye and wheat intake. Quality control samples were included in each batch to 
ensure adequate precision. AR were extracted with diethyl ether and further cleaned 
up with solid phase extraction (SPE). AR were made more volatile through derivat-
isation with trifluoroacetic anhydride (TFAA) and analyzed with gas chromatog-
raphy-mass spectrometry (GC-MS). The coefficient of variation (CV) within batch-
es were ≤ 9% and between batches ≤ 15% except of one homolog, C25. No signifi-
cant difference was found in total AR concentration between the lifestyle interven-
tion and control groups or between subjects who developed diabetes during follow 
up and non-diabetic controls. Even if there was no difference in plasma AR be-
tween the  lifestyle intervention- and control groups there was a significant differ-
ence in fiber intake (p=0.001). The Finnish population consumes large amounts of 
whole grain in the form of rye bread. When the subjects were advised to raise their 
consumption of dietary fiber during the  lifestyle intervention, it is likely they did 
this with other foods than rye and wheat sources. The main findings of this study 
were a positive correlation between the AR C17/C21 ratio and time to T2D diagno-
sis (p=0.027) and the fact that the AR C17/C21 ratio was higher within non-
diabetics than diabetics (p=0.025). This indicates that individuals with a high intake 
of whole grain rye develop T2D later than those with a low intake, or does not de-
velop it at all, i.e. that whole grain rye is protective. This should be confirmed with 
more sophisticated analysis of data in the present study but that is out of scope for 
this study. 
 
Keywords: T2D, whole grain, rye, wheat, C17/C21, biomarker, alkylresorcinols, 
analysis, gas chromatography- mass spectrometry (GC-MS). 
 
 
 
 
 
 
Sammanfattning 
 
Typ 2-diabetes är ett stort folkhälsoproblem. Prevalensen ökar globalt och genererar 
en stor ekonomisk kostnad för samhälle och lidande för individen. Det har i epide-
miologiska studier visat sig att fullkorn skyddar mot typ 2-diabetes. Mekanismerna 
bakom fullkorns positiva inverkan är inte kartlagda men reducerat energiintag, ökad 
insulinkänslighet och ökad glukostolerans är faktorer som har föreslagits och delvis 
bekräftats i studier. Alkylresorsinoler (AR) är fenoliska lipider vilka endast finns i 
de yttersta skikten av råg och vete bland vanliga livsmedel. AR används idag som 
biomarkör av fullkornsintag av råg och vete. En finsk studie i förebyggande av 
diabetes, The Finnish Diabetes Prevention Study (DPS), startade 1993 med syfte att 
utvärdera ett intensivt diet- och träningsprogram för personer med nedsatt glukosto-
lerans. Syftet med den här studien var att undersöka om det fanns en skillnad i full-
kornsintag mellan de som inte utvecklat- och de som utvecklat typ 2 diabetes under 
en åtta års period. Studien gjordes på en del av deltagarna i DPS. Syftet var också 
att undersöka fullkornsintaget hos de som fick livsstils intervention och de som inte 
fick det. Fullkornsprodukterna råg och vete mättes genom AR i plasma. Kontroll-
prover användes för att säkerställa precision. AR extraherades med dietyl eter och 
renades med fast-fas-extraktion. AR gjordes mer flyktiga med derivatisering av 
trifluoracetylacetat och analyserades med gas kromatografi-mass spektrometri (GC-
MS). CV värdet av kontrollproverna inom batcherna var ≤ 9% och mellan batcherna 
≤ 15% med undantag av homolog C25. Det var ingen signifikant skillnad mellan 
totala AR och interventionsgrupperna eller mellan totala AR och de som utvecklade 
diabetes och de som inte gjorde det. Även om det inte fanns en skillnad mellan AR 
intag och interventionsgrupperna fanns det en signifikant skillnad i fiberintag 
(p=0.001). Den finska populationen konsumerar mycket fullkorn och den största 
delen utgörs av rågbröd. När deltagarna fick rådet att öka sitt fiberintag gjordes det 
troligtvis genom andra källor än via råg- och vete produkter. De viktigaste fynden i 
denna studie är det positiva förhållandet mellan AR kvoten C17/C21 och tiden till 
att utveckla typ 2-diabetes (p=0.027) och den högre kvoten av C17/C21 hos icke 
diabetiker än diabetiker (p=0.025). Detta indikerar att individer med ett högt intag 
av fullkornsråg senare utvecklar typ 2 diabetes än de med ett lågt intag samt att en 
högre fullkornskonsumtion av råg kan förebygga en utveckling av diabetes typ 2. 
Resultaten bör bekräftas med mer avancerade analysmetoder men det ligger utanför 
detta kandidatarbete. 
 
Nyckelord: Typ 2-diabetes, fullkorn, råg, vete, C17/C21, alkylresorcinoler, biomar-
kör, analys, gas kromatografi-mass spektrometri (GC-MS). 
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Abbreviations 
 
AR  Alkylresorcinols 
CV The coefficient of variation  
CVD  Cardiovascular diseases 
DPS The Finnish Diabetes Prevention Study 
FFQ Food frequency questionnaire 
GC-MS Gas chromatography-mass spectrometry 
HDL  High density cholesterol 
IGT  Impaired glucose tolerance 
SD Standard deviation 
SPE Solid phase extraction 
T2D Type 2 diabetes 
TFAA Trifluoroacetic anhydride 
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1 Introduction 
1.1 Background 
1.1.1 Diabetes 
 
Type 2 diabetes (T2D) is a public health problem of great concern worldwide. It is 
increasing globally due to population growth, urbanization, aging, physical inac-
tivity and obesity (Wild et al., 2004). The increase is most drastic in developing 
countries where the western diet is adopted in the same time as a change in life-
style is implied. In year 2010 the global prevalence of T2D was 6.4% and the es-
timation for year 2030 is 7.7%. In numbers, 285 million people had diabetes year 
2010 and 439 million are expected to have it year 2030 (Shaw, Sicree & Zimmet, 
2010). This increase will generate a huge economic burden for societies and prob-
lem for individuals. More preventive actions are needed to lower the prevalence of 
T2D (Zhang et al., 2010). The health burden is mostly due to atherosclerotic vas-
cular diseases, neuropathic and microvascular complications that follows with 
T2D. Examples of clinical complications are reduced eye vision, kidney failure, 
heart attacks, stroke, amputation and sexual dysfunction (American diabetes asso-
ciation, 2014). 
 
Insulin resistance is a prestage of T2D and is defined as an inability for the liver, 
adipose tissue and skeletal muscles to respond to insulin and this may develop into 
T2D when the B cells in the pancreas fail to produce enough insulin. Type 1 dia-
betes is different from type 2 with no production of insulin at all. When it debut 
there can still be production but with time it will decline. Type 1 diabetes is an 
autoimmune disease with destruction of the beta cells (Egan & Dienneen, 2014). 
T2D stands for 90-95% of all diabetes cases. It often develops asymptomatically 
with hyperglycemia which can have and injurious effect on many organs before 
the disease is discovered (American diabetes association, 2014). T2D may develop 
as a result of the metabolic syndrome. Except of abdominal obesity two out of the 
following four criteria are needed for a diagnosis of the metabolic syndrome; ele-
vated blood pressure, high serum triglycerides, low levels of high density choles-
terol (HDL) and elevated fasting glucose (both for levels corresponding to con-
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firmed diabetes and levels indicating on pre-diabetes) (Alberti, Zimmet & Shaw, 
2006). 
 
1.1.2 Whole grain 
Whole grain are in epidemiological studies associated with beneficial health out-
comes such as reduced risk of developing T2D (de Munter et al., 2007, Cho et al., 
2013, Parker et al., 2013), cardiovascular diseases (CVD) (Flight and Clifton, 
2006) and some cancers (Kyrø et al., 2014, Schatzkin et al., 2008). Whole grain 
shall consist of an intact, cracked, flaked or ground kernel after the removal of the 
inedible parts (husks and hulls). The bran, germ and endosperm should be present 
in the proportions as they naturally are in the intact kernel (Willem van der Kamp 
et al., 2014). The nutrients in whole grain are mainly concentrated in the bran and 
germ and consist of resistant starch, oligosaccharides, certain fatty acids, mole-
cules with antioxidant properties, vitamins, minerals and phenolic compounds. In 
refined grains, the bran and most of the germ have been removed during pro-
cessing. The endosperm remains and is rich in starch and low in nutrients (Slavin 
et al., 1999). The mechanism behind the benefits of whole grain consumption and 
T2D is not fully understood. Studies have shown that whole grain consumption 
offer protection by mechanisms as decreased energy intake, higher insulin sensi-
tivity and improved glucose tolerance (Ludwig DS et al., 1999). Dietary fibers 
slower the absorption and digestion of carbohydrates and there will be a lower 
glucose response and less insulin is required. Once the fibers are processed the 
vitamins, minerals, fatty acids and phytochemicals are free to be absorbed (Slavin 
et al., 1999).  Scandinavians consume more whole grain than US and UK (Jacobs 
et al., 2001). It is difficult to compare studies of whole grain intake due to vague 
and different definitions of whole grain foods. Therefore have objective ways of 
measuring whole grain intake been requested (Lang and Jebb, 2003). 
1.2 Biomarkers 
 
There is a lot of research about food intake and risk of diseases as endpoints. Ex-
cept of bias from unclear definitions of whole grain there are also common random 
and systematic errors from gathering information by self-reporting as food fre-
quency questionnaires (FFQ). For example under- or over reporting of food intake, 
subjects report what is believed to be healthy or asked for or what is thought the 
investigator wants to hear. Instead of collecting all the information in this subjec-
tive manner has there been a need for an objective way of measuring (Lissner et 
al., 2007). A biomarker is a substance that can be measured in body fluids as blood 
and urine and it has a biological effect on humans. Also biomarkers can be biased 
by factors as health status, biochemical availability, age and genetics. The optimal 
way to avoid bias is to combine both biomarkers and subjective measurements 
such as food frequency questionnaires, 24 hour recall et cetra (Willett, 2012).  
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1.3 Alkylresorcinol as a biomarker of whole grain rye and wheat 
 
There has been a lot of research to investigate if the phytochemical alkylresor-
cinols (AR) can be a potential biomarker of wholegrain (Chen et al., 2004, 
Landberg et al., 2008b, Ross, 2012,  Magnusdottir et al., 2013). AR, 1,3-
dihydroxy-5-alkylbenzene, are phenolic lipids. They are found in a wide variety of 
derivate in a number of bacteria and fungi but most are of plant origin. Interesting 
for the food area is the significant amount found in some members of the family 
Gramine (Kozubek and Tyman, 1999). Higher levels have been found in wheat 
(489-1429 µg/g), rye (720-761 µg/g) and triticale (439-647µg/g). Lower levels 
have been found in barley (42-51 µg/g) and nothing in millet and maize (Ross et 
al., 2003b).  
 
ARs are located in high concentrations in the bran fraction (Landberg et al., 
2008a) and only in minute quantities in the endosperm (Ross and Kochhar, 2009). 
With this location they were though of suitable biomarkers of whole grain rye and 
wheat intake (Landberg et al., 2008a). Several studies have also shown that the 
concentration of ARs in plasma corresponds to the intake of whole grain rye and 
wheat intake (Landberg et al., 2008b, Landberg et al., 2009a, Linko-Parvinen et 
al., 2007). Other factors that make ARs good biomarkers are that they are ab-
sorbed by humans, they remain  undestroyed during baking or other heat treatment 
(Ross et al., 2003a) and they can be measured in plasma and their metabolites can 
be measured in urine (Landberg et al., 2009). 
1.4 The chemistry of alkylresorcinols 
 
AR molecules consist of a resorcinol with an alkyl group (Figure 1). They have an 
amphiphilic character due to the hydrophilic dihydroxylbenzene group (resorcinol) 
and the lipophilic alkyl group. In rye and wheat, the main homologs have odd 
numbered alkyl chains with 17-25 hydrocarbons (Kozubek and Tyman, 1999). A 
study performed by Ross et al (2001) found the proportions of each alkyl group in 
rye to be C17:0  23%, C19:0 32%, C 21:0 26%, C23:0 11% and C25:0 8%. It dif-
fers between types of rye product but broadly the proportions are as mentioned. In 
wheat it is more or less similar but with a lower amount of C17:0 and slightly 
higher of C21:0 (Ross et al., 2003b). The alkyl chains are mostly saturated >80%, 
but unsaturation does also occur, especially in rye (Ross et al., 2003b). 
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Figure 1. The structure of alkylresorcinols. The most common homologs in cereals have an odd 
numbered alkyl chain with 17-25 hydrocarbons on position 5 (R).  
The ratio of the AR homologs C17:0/C21:0 has been found to distinguish between 
cereal species (Chen et al. 2004). The ratio in wheat is 0.1 and in rye 1.0. This can 
be used to distinguish between rye and wheat in food products (Chen et al., 2004). 
This ratio can also reflect the relative intake of rye and wheat in plasma samples 
(Linko-Parvinen et al., 2007). A study made by Magnusdottir et al. (2014) showed 
that a higher ratio was associated with better insulin sensitivity.  Although the ratio 
in rye is 1.0 it is normally between 0.6-0.8 in fasting plasma samples (Linko-
Parvinen et al., 2007). There is need of more research  to conclude why the ratio is 
lower but it probably has to do with a faster metabolism of the homolog C17:0 
(Ross, 2012). 
 
Whole grain consists of many components and the mechanisms of the benefits 
with whole grain are still obscure. In the case of ARs they have been thought to 
have antioxidant properties but the results have been poor compared to alpha-
tocopherol in vitro (Kamal-Eldin et al., 2001). They do have antifungal and anti-
microbial activities (Kozubek and Tyman, 1999). In vitro experiments have shown 
an anticancer effects and an ability to inhibit enzymes. One inhibition that has 
been observed is a precursor step of forming triacylglycerol. Studies has also 
shown that a diet high in AR has led to lower levels of cholesterol in the plasma in 
animal trials (Ross, Kamal-Eldin & Aman, 2004).  
 
1.5 The Finnish Diabetes Prevention Study (DPS) 
 
The DPS study started in 1993 with the aim to evaluate if an intensive diet and 
exercise program could prevent or delay T2D in people with impaired glucose 
tolerance (IGT). It was also evaluated what effect the program had on the athero-
sclerotic vascular diseases and of the rate of cardiovascular events. Test subjects 
were divided in an  lifestyle intervention and a control group. The control group 
did annually receive basic information about the benefits with improved diet, 
weight reduction and physical activity. The subjects in the lifestyle intervention 
group received individual guiding several times each year. The guiding included 
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advice about diet with the aim of reducing weight and in reducing the intake of 
saturated fats and increase intake of dietary fiber. Each individual received support 
with their physical activity. A consistent weight reduction and a higher tolerance 
for glucose were observed in the lifestyle intervention group during the follow up 
years. After 4 years, 11% of the subjects in the lifestyle intervention group had 
diabetes and the number in the control group was 23%. The lower incidence of 
diabetes in the lifestyle intervention group shows that T2D can be prevented 
and/or delayed with change of lifestyle (Tuomilehto et al., 2001). There has been 
many follow up studies on DPS after the end of the lifestyle intervention (4 years 
after start up). Except of the aspect of T2D and obesity, researchers have been 
looking on how lifestyle changes can affect depression (Ruusunen et al., 2012). 
There has also been studies on the possibility that these lifestyle changes can affect 
the telomere length which is considered a biomarker for aging (Hovatta et al., 
2012). 
1.6 Aim 
 
The aim of this study was to investigate if there was a difference in whole grain 
intake among non-diabetics and people who developed diabetes during an 8 years 
period after the study started (irrespective of dietary intervention). The aim was 
also to evaluate the difference in whole grain wheat and rye intake between sub-
jects who were in the lifestyle intervention group compared with subjects in the 
control group. Whole grain wheat and rye was measured by plasma AR. 
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2 Materials and Methods 
2.1 Samples 
 
From the DPS study did we get access to a subsample of 100 samples from sub-
jects who developed T2D and 100 control subjects, irrespective of treatment. In 
total 186 plasma samples collected between the years 1996-1998 were used. The 
samples were analyzed with the knowledge who had developed T2D and those 
who had not. The batches were run with 50/50 from each group. The samples had 
been stored in -70 °C and were thawed in room temperature before analysis. 
 
2.2 Method 
 
The method used for quantifying ARs in plasma was the one designed by Land-
berg, Åman & Kamal-Eldin (2009b), with small modifications. ARs were extract-
ed with diethyl ether. The samples were further cleaned up with a solid phase ex-
traction robot (SPE). The final elute in the SPE was made with 2 % formic acid in 
MeOH instead of 2% acetic acid in MeOH as in the method of Landberg et al 
(2009b). Another deviation from the method was that the derivatization of the ARs 
was done with 200 µl trifluoroacetic anhydride (TFAA) instead of silylation. 
Thereafter the samples were incubated in 40 °C for 30 minutes and transferred to 
vials with inserts. The vials with TFAA was left to dry in 60 °C and then 20 µl of 
undecane was added as solvent. Finally, the samples were analyzed by gas chro-
matography-mass spectrometry (GC-MS) with EI-ionization. Quality control sam-
ples (n=4) were included in each batch to verify the within- and between batch 
precision (CV<15%). An internal standard, AR C20, was used for calibration. For 
further details about the method see Landberg et al (2009b). 
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2.3 Statistics 
 
One-way ANOVA, regression and correlation analyses were used for statistical 
inference. ANOVA was used to evaluate differences in total AR, sex, BMI, total 
fiber/1000kcal and the AR C17:0/C21:0 ratio between the lifestyle intervention- 
and control groups. The same method was used to calculate the differences be-
tween diabetics and non-diabetics for total AR, total fiber/1000kcal and the AR 
C17:0/C21:0 ratio. Regression analysis was conducted with total AR as dependent 
variable and dietary fibre, BMI and sex as independent variables. Correlation 
analysis was conducted with total AR and the AR C17/C21 ratio, the AR C17/C21 
ratio and time to diabetes diagnosis, the AR C17/C21 ratio and total fi-
ber/1000kcal, the AR C17/C21 ratio and carbohydrate (E%) and carbohydrate 
(E%) and total fiber/1000kcal. 
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3 Result 
The alkylresorcinol concentrations in plasma samples were analyzed in seven 
batches. Table 1 illustrates the coefficient of variation (CV) within the batches of 
the quality control samples. The CV was <15% in all batches.  
 
Table 1. The CV of the homologs within the batches and mean value of CV for each homolog. The 
mean value was used as an estimator of the within-subject variation.  
Batch 
                                 CVwithin batch 
 
C17 C19 C21 C23 C25 
1 2 3 3 9 5 
2 4 3 3 5 7 
3 5 5 4 8 12 
4 6 4 4 9 9 
5 3 6 3 4 11 
6 6 3 6 5 9 
7 8 6 4 5 9 
Mean 5 4 4 6 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
13 
 
The CV between the batches of each homolog of the quality control samples were 
≤15% except of C25. The CV of total value of the batches is low, 6.0 (Table 2).  
 
Table 2. The mean value of AR for each homolog for each batch of quality control samples (nmol/L). 
The mean value (nmol/L), standard deviation (SD) and CV (%) of each homolog between the batches 
and of the total amount of AR between the batches. 
Batch C17
mean
 C19
mean
 C21
mean
 C23
mean
 C25
mean
 Total AR 
1 9 27 33 10 10 88 
2 9 28 38 12 8 95 
3 10 30 36 8 6 90 
4 10 31 39 8 6 94 
5 9 28 37 9 7 92 
6 11 32 39 10 6 100 
7 12 35 39 10 9 104 
Mean 10 31 37 10 7 95 
SD 1 3 2 1 2 6 
CV 12 9 6 15 22 6 
 
 
There was no significant difference in total AR concentration between the lifestyle 
intervention and control groups, or between sex or BMI classes within the dietary 
intervention groups (Table 3). A multiple regression analysis where total AR was 
regressed on BMI and sex separately or together was not statistically significant 
p=0.228 (data not shown). Even if there was no difference in total AR between the  
lifestyle intervention and control groups, there was a significant difference for 
total fiber/1000 kcal, p=0.001, Table 3 (Figure 2 for distribution). Based on the 
recommendations for women to consume ~ 2000kcal and men ~2500kcal/day 
(Mann & Truswell, 2007) did women in the intervention group have an intake of 
27g fiber/day and in the control group 22.2g/day. Men in the intervention group 
have an intake of 33.8g fiber/day and 27.8g fiber/day in the control group (based 
on median value of fiber intake/1000kcal, Table 3). The difference of the AR 
C17:0/C21:0 ratio between the lifestyle intervention and control groups was not 
significant (Table 3). The lowest value of AR within the subjects was 11.5 and the 
highest 419.4 nmol/L (data not shown).  
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Table 3. The average and median of total AR in the case- and control group. The average and medi-
an of total AR in aspect of sex and BMI within the case and control groups. Total fiber and the AR 
C17/C21 ratio between the lifestyle intervention and control groups ( p=0.05). 
   Intervention 
n=94 
  Control 
n= 92 
 
        
  Average Median T test  Average Median 
P 
value  
Total AR*  78.5 59.4  77.3 55.2 0.875 
        
Sex Female 80.6 59.4  74.4 53.7  
 Male 74.3 62.1 0.622 82.6 59.4 0.595 
        
BMI 
(23.5-
30.0) 77.8 65.7  89.2 62.2  
 
(30.1-
47) 79.1 58.5 0.922 64.9 45.5 0.078 
Total fiber/ 
(1000kcal)  
 
14.0 
 
13.5  12.2 11.1 
 
0.001 
C17/C21  0.4 0.4  0.38 0.35 
 
0.471 
* Analyses done on log transformed values of AR to aquire normal distribution (Figure 3). 
 
 
 
 
 
 
Figure 2. A boxplot of the total fiber intake/1000kcal in the intervention and control groups. (1= 
intervention, 2= control) 
 
No significant difference in total AR (log transformed to acquire normal distribu-
tion, Figure 3) or fiber intake/1000kcal between diabetics and non-diabetics was 
found (Table 4). However, the AR C17:0/C21:0 ratio was significantly higher 
among non-diabetics than for diabetics, p= 0.025, (Figure 4 for distributions). No 
correlation between total AR and sex or total AR and BMI at baseline was found, 
irrespective of other variables as lifestyle intervention or control groups and dia-
betics/non-diabetics (data not shown). 
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Table 4. Plasma total AR, the AR C17:0/C21:0 ratio and total fiber/1000kcal intake among diabetics 
and non-diabetics (p<0.05).  
 Diabetics 
n= 90 
Non-diabetics 
n=96 
 
Variable Mean Median Mean Median p-value 
Total AR* 82.1 60.3 74.1 55.4 0.514 
C17:0/C21:0 0.36 0.32 0.42 0.025 0.025 
Total fiber/ 
1000kcal 
12.8 12.6 13.34 12.2 0.356 
* Analyses done on log transformed values of AR to aquire normal distribution (Figure 3). 
 
 
Figure 3. Normal distribution after log transformation of total AR. 
 
 
Figure 4. Boxplot of the AR C17:0/C21:0 ratio between non-diabetics and diabetics. (0=non-
diabetic, 1=diabetic) 
 
 
 
 
 
16 
 
Total plasma AR was not correlated with the AR C17:0/C21:0 ratio. Moreover, a 
significant positive correlation was found between the AR C17:0/C21:0 ratio and 
time to development of T2D. Other significant correlations were between the AR 
C17:0/C21:0 ratio and total fiber/1000kcal, AR C17:0/C21:0 ratio and carbohy-
drate (E%) and carbohydrate (E%) and total fiber/1000kcal (Table 5).  
 
Table 5. Correlation between variables (p<0.05). 
Correlations 
Variable Variable r P-value 
Total AR C17/C21 0.0006 0.749 
C17/C21 Time to diabetes diagno-
sis 
0.026 0.027 
C17/C21 Total fiber/1000kcal 0.053 0.001 
C17/C21 Carbohydrate (E%) 0.021 0.046 
Carbohydrate (E%) Total fiber/1000kcal 0.197 <0.0001 
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4 Discussion 
 
The within- and between batch difference of CV for the quality control samples 
were <15% except of homolog C25:0. There has been a consistent problem in the 
lab with this homolog due to its somewhat different behavior in the GC-MS. The 
reasons for higher CV may be related to a high boiling point and polarity of this 
homologue. Reasons for variations could also be due to insufficient extraction 
with diethyl ether or that some of the substance did not come out from the GC-
MS, or were delayed giving them another retention time. The reason for the lowest 
CV for AR C19:0 and C21:0 is probably due to their similarity with the internal 
standard, C20:0. Even if C25:0 had a high CV it is also the homolog that affects 
the total amount of AR least. C25:0 represents the lowest part of the total content 
of AR, C17:0- C25:0 (Ross et al., 2003b). There were also some disparities with 
C23:0. This is probably due to the possible overlap of retention time with choles-
terol in the GC-MS. The amount of cholesterol in the blood is much higher than 
the homolog C23:0. They are not in the same selected visible window in the GC-
MS but it can disturb the measurements of the homolog C23:0. However, overall, 
the results were acceptable. 
 
In this study, there was no difference in total AR between the intervention and 
control groups. However, a significant difference in total dietary fiber intake be-
tween the lifestyle intervention and control groups was found, with a higher intake 
in the intervention group. Finland is a country with high intake of dietary fiber and 
rye is the largest source. Finns do not seem to associate rye with a healthier life-
style due to its already well-established role in the diet (Prättälä, Elasoja & 
Mykkänen,  2001). The subjects in the intervention group were advised to raise 
their consumption of dietary fiber. This was most likely done with other sources 
than cereals such as vegetables, fruits and beans. The median of the AR 
C17:0/C21:0 ratio was 0.40 in the intervention group and 0.35 in the control 
group, indicating that also the rye intake was somewhat increased but the differ-
ence was not significant. The AR C17:0/C21:0 ratio was higher compared to other 
studies which corresponds well with the higher consumption of rye in Finland 
compared with other Nordic countries. Previous studies have shown that a high rye 
intake, measured with the AR C17:0/C21:0 ratio is associated with insulin sensi-
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tivity (Magnusdottir et al. 2014), but whole grain rye intake may already be high 
in the present study and no further improvement may be possible. 
 
There was also no significant difference in total AR or total fiber between diabet-
ics and non-diabetics. Very interesting findings of the present study were the posi-
tive correlation with the AR C17:0/C21:0 ratio and time to diagnosis of T2D and 
higher value of the AR C17:0/C21:0 ratio for non-diabetics than diabetics. The 
positive correlation with the AR C17:0/C21:0 ratio and time to diagnosis of T2D 
is in accordance with a study made by Magnusdottir et al (2014) and may support 
the idea that a diet rich in whole grain rye increase the insulin sensitivity and 
thereby increase the time to diagnosis of T2D. This specific finding of rye con-
sumption could be an important aspect in the diet for preventing T2D.  
  
Earlier studies have found a difference in total AR between men and women 
(Montonen et al., 2012, Landberg et al., 2013) but no such difference was found in 
this study.  
 
The latest edition of the Nordic nutrition recommendations (2012) recommends a 
daily intake of dietary fiber between 25-35 g/day. The fiber intake in this study 
(Table 3) more or less reflects what is found in earlier studies in Finland. A cohort 
study of 22 000 finns found the median consumption to be 26 g/day (Pietinen et 
al., 1996). The Finnish population consumes more dietary fiber than many other 
countries. The mean consumption of dietary fiber for males in China is 19.4 g/day 
and17.6 g/day for women (Wang et al., 2011), the average intake in Unites States 
is between 15.7-17.0 g/day depending on ethnic group (King, Mainous & Lam-
bourne, 2012). A too low intake in children has  been noted in Germany (Alexy, 
Kersting & Sichert-Hellert, 2006)) and Belgium (Bosscher, Van Caillie-Bertrand 
& Deelstra, 2002) and in England (Muñoz et al., 1997).   
 
The spread of AR values is expected and seen in other studies. Extremely high 
values may be due to consumption of whole grain rye products just before blood 
sampling. The median value of AR in the lifestyle intervention and control groups 
(Table 3) are in the same range as some studies (Landberg et al., 2013, Ross et al., 
2012) and others have a higher baseline value (Magnusdottir et al., 2013). It could 
be expected that the value would be higher than in studies done in other countries 
due to the high consumption of whole grain products in Finland.  
 
The positive correlations between carbohydrate E% and fiber/1000kcal, AR 
C17:0/C21:0 ratio and carbohydrate and AR C17:0/C21:0 ratio and fiber/1000kcal 
are obvious due to the fact they are from the same source.  
 
An improved method for the analysis of the homolog C25:0 is needed and could 
be a subject for future research. Further studies should also verify the current find-
ings about the AR C17:0/C21:0 ratio and its delayed onset of T2D.  
 
More advanced statistical methods will be used to investigate the data from the 
current study. But this is out of the scope of the current study. 
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5 Conclusion 
 
No significant difference in plasma AR and thereby intake of whole grain cereals 
was found between diabetics and non-diabetics or between the lifestyle interven-
tion and control groups. At the same time there was a higher consumption of fiber 
in the intervention group. The increase of fiber intake in the intervention group is 
probably from other sources than whole grain wheat and rye. The AR C17:0/C21:0 
ratio was positively correlated with time to diagnosis of T2D and the C17:0/C21:0 
ratio was higher within non-diabetics than diabetics. This indicates that a high 
whole grain rye intake may have a positive impact on the development of T2D. 
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